Search filters

List of works by William Evan Secor

A diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: rationale and target product profiles

scientific article

A schistosomiasis research agenda

scientific article

Association of the gene polymorphisms IFN-gamma +874, IL-13 -1055 and IL-4 -590 with patterns of reinfection with Schistosoma mansoni

scientific article published in 2009

Associations between schistosomiasis and HIV-1 acquisition risk in four prospective cohorts: a nested case-control analysis

scientific article published on 01 June 2020

Author Correction: Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy

scientific article published on 01 September 2019

Circulating Anodic Antigen (CAA): A Highly Sensitive Diagnostic Biomarker to Detect Active Schistosoma Infections-Improvement and Use during SCORE

scientific article published on 12 May 2020

Circulating CD23+ B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments

scientific article published on January 2009

Cluster randomized trial comparing school-based mass drug administration schedules in areas of western Kenya with moderate initial prevalence of Schistosoma mansoni infections.

scientific article

Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans

scientific article

Early lessons from schistosomiasis mass drug administration programs

scientific article

Eliminating lymphatic filariasis, onchocerciasis, and schistosomiasis from the americas: breaking a historical legacy of slavery

scientific article

Evaluation, Validation, and Recognition of the Point-of-Care Circulating Cathodic Antigen, Urine-Based Assay for Mapping Schistosoma mansoni Infections

scientific article published on 12 May 2020

Five-Year Impact of Different Multi-Year Mass Drug Administration Strategies on Childhood Schistosoma mansoni-Associated Morbidity: A Combined Analysis from the Schistosomiasis Consortium for Operational Research and Evaluation Cohort Studies in the

scientific article published on 01 December 2019

Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya.

scientific article published on 23 April 2018

Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries

scientific article

Genetic diversity of Trichomonas vaginalis clinical isolates determined by EcoRI restriction fragment length polymorphism of heat-shock protein 70 genes.

scientific article published on February 2009

Geographic distribution of schistosomiasis and soil-transmitted helminths in Western Kenya: implications for anthelminthic mass treatment.

scientific article published in September 2003

High prevalence of schistosomiasis in Mbita and its adjacent islands of Lake Victoria, western Kenya

scientific article published on December 3, 2012

Higher percentages of circulating mast cell precursors correlate with susceptibility to reinfection with Schistosoma mansoni

scientific article

Identification of Cytokeratin 18 as a Biomarker of Mouse and Human Hepatosplenic Schistosomiasis

scientific article published on February 28, 2011

Idiotypes expressed early in experimental Schistosoma mansoni infections predict clinical outcomes of chronic disease

scientific article

Immunology of human schistosomiasis

scientific article

Immunoregulation and World Health Assembly resolution 54.19: why does treatment control morbidity?

scientific article published on June 2004

Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of Schistosoma mansoni and Schistosoma haematobium Infection in Africa

scientific article published on 12 May 2020

Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study

scientific article published on 12 March 2018

Impact of Mothers' Schistosomiasis Status During Gestation on Children's IgG Antibody Responses to Routine Vaccines 2 Years Later and Anti-Schistosome and Anti-Malarial Responses by Neonates in Western Kenya.

scientific article published on 18 June 2018

Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya

scientific article

Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni

scientific article

Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni

scientific article published in 2010

Interactions between schistosomiasis and human immunodeficiency virus in Western Kenya

scientific article (publication date: August 2004)

Lessons Learned in Conducting Mass Drug Administration for Schistosomiasis Control and Measuring Coverage in an Operational Research Setting

scientific article published on 12 May 2020

Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy

scientific article published on 24 June 2019

Osteopontin Is Upregulated in Human and Murine Acute Schistosomiasis Mansoni

scientific article

Persistent Hotspots in Schistosomiasis Consortium for Operational Research and Evaluation Studies for Gaining and Sustaining Control of Schistosomiasis after Four Years of Mass Drug Administration of Praziquantel

scientific article published on 01 September 2019

Proteomic changes at 8weeks after infection are associated with chronic liver pathology in experimental schistosomiasis

scientific article published on January 10, 2012

Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries

scientific article published on 29 September 2017

Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni

scientific article

Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study

scientific article published in August 2002

SCORE Studies on the Impact of Drug Treatment on Morbidity due to Schistosoma mansoni and Schistosoma haematobium Infection

scientific article published on 12 May 2020

Schistosomiasis Induces Persistent DNA Methylation and Tuberculosis-Specific Immune Changes

scientific article published on 11 May 2018

Schistosomiasis in Africa: Improving strategies for long-term and sustainable morbidity control.

scientific article published on 28 June 2018

Serum osteopontin is a biomarker of severe fibrosis and portal hypertension in human and murine schistosomiasis mansoni

scientific article

Short report: Childhood coinfections with Plasmodium falciparum and Schistosoma mansoni result in lower percentages of activated T cells and T regulatory memory cells than schistosomiasis only.

scientific article

Short report: Evaluation of hepatic fibrosis in persons co-infected with Schistosoma mansoni and human immunodeficiency virus 1.

scientific article published in December 2004

Survey of Schistosomiasis in Saint Lucia: Evidence for Interruption of Transmission

scientific article published on 01 April 2020

T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment

scientific article published on October 2007

Water-based interventions for schistosomiasis control

scientific article

When Should the Emphasis on Schistosomiasis Control Move to Elimination?

scientific article published on 15 August 2018

Young Adults in Endemic Areas: An Untreated Group in Need of School-Based Preventive Chemotherapy for Schistosomiasis Control and Elimination

scientific article published on 05 September 2018